Bronnen:
- Choquette D, Bessette L, Alemao E, et al. Abatacept Shows Better Sustainability Than TNF Inhibitors When Used Following Initial Biologic DMARD Failure in the Treatment of RA: 8 Years of Real-World Observations from the Rhumadata® Clinical Database and Registry. ACR 2017, abstract 1817.